Evidence map›Paper›PMID 26858399›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting.

Xuanyi Ma, Xin Qu, Wei Zhu, Yi-Shuan Li, Suli Yuan, Hong Zhang, Justin Liu, Pengrui Wang, Cheuk Sun Edwin Lai, Fabian Zanella and 4 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 373 papers.

0numbers the graph read from it
0cells of the map it votes in
373citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

373 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Advances in vascularized organoids.Chinese medical journal · 2026
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

313 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Xuanyi MaDepartment of Bioengineering, University of California, San Diego, La Jolla, CA 92093; Department of NanoEngineering, University of California, San Diego, La Jolla, CA 92093;
Xin QuDepartment of NanoEngineering, University of California, San Diego, La Jolla, CA 92093;
Wei ZhuDepartment of NanoEngineering, University of California, San Diego, La Jolla, CA 92093;
Yi-Shuan LiDepartment of Bioengineering, University of California, San Diego, La Jolla, CA 92093;
Suli YuanDepartment of Bioengineering, University of California, San Diego, La Jolla, CA 92093;
Hong ZhangChemical Engineering Program, University of California, San Diego, La Jolla, CA 92093;
Justin LiuMaterials Science and Engineering Program, University of California, San Diego, La Jolla, CA 92093;
Pengrui WangMaterials Science and Engineering Program, University of California, San Diego, La Jolla, CA 92093;
Cheuk Sun Edwin LaiChemical Engineering Program, University of California, San Diego, La Jolla, CA 92093;
Fabian ZanellaDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093;
Gen-Sheng FengDepartment of Pathology, University of California, San Diego, La Jolla, CA 92093.
Farah SheikhDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093;
Shu ChienDepartment of Bioengineering, University of California, San Diego, La Jolla, CA 92093; shuchien@ucsd.edu chen168@eng.ucsd.edu.
Shaochen ChenDepartment of Bioengineering, University of California, San Diego, La Jolla, CA 92093; Department of NanoEngineering, University of California, San Diego, La Jolla, CA 92093; shuchien@ucsd.edu chen168@eng.ucsd.edu.

Funding

U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
The molecular mechanisms underlying arrhythmogenic right ventricular dysplasia/cardiomyopathyR01HL095780 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SHEIKH, FARAH · 2009 to 2018
$3.9M
Molecular and Cellular Communications in Liver TumorigenesisR01CA176012 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FENG, GEN-SHENG · 2014 to 2019
$1.7M
A Microfabrication Platform for Direct Printing Vascularized Functional Tissue CoR01EB012597 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHEN, SHAOCHEN · 2010 to 2013
$1.4M
Biomimetic design of human induced pluripotent stem cells on a chipR21EB017876 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHEN, SHAOCHEN · 2013 to 2014
$419k
NCI NIH HHS R01 CA176012NHLBI NIH HHS R01 HL095780NIBIB NIH HHS R01 EB012597NIBIB NIH HHS R01EB012597NIBIB NIH HHS R21 EB017876NIBIB NIH HHS R21EB017876NINDS NIH HHS P30 NS047101
6 · The paper itself

Abstract

The functional maturation and preservation of hepatic cells derived from human induced pluripotent stem cells (hiPSCs) are essential to personalized in vitro drug screening and disease study. Major liver functions are tightly linked to the 3D assembly of hepatocytes, with the supporting cell types from both endodermal and mesodermal origins in a hexagonal lobule unit. Although there are many reports on functional 2D cell differentiation, few studies have demonstrated the in vitro maturation of hiPSC-derived hepatic progenitor cells (hiPSC-HPCs) in a 3D environment that depicts the physiologically relevant cell combination and microarchitecture. The application of rapid, digital 3D bioprinting to tissue engineering has allowed 3D patterning of multiple cell types in a predefined biomimetic manner. Here we present a 3D hydrogel-based triculture model that embeds hiPSC-HPCs with human umbilical vein endothelial cells and adipose-derived stem cells in a microscale hexagonal architecture. In comparison with 2D monolayer culture and a 3D HPC-only model, our 3D triculture model shows both phenotypic and functional enhancements in the hiPSC-HPCs over weeks of in vitro culture. Specifically, we find improved morphological organization, higher liver-specific gene expression levels, increased metabolic product secretion, and enhanced cytochrome P450 induction. The application of bioprinting technology in tissue engineering enables the development of a 3D biomimetic liver model that recapitulates the native liver module architecture and could be used for various applications such as early drug screening and disease modeling.

Indexed as

Printing, Three-DimensionalAlbuminsBiomimeticsBioprintingCell Culture TechniquesCell DifferentiationGene ExpressionHepatocytesHumansInduced Pluripotent Stem CellsLiverTissue EngineeringAlbumins3D bioprintingbiomaterialsin vitro hepatic modeliPSCtissue engineering

Identifiers

PMID26858399
PMCPMC4776497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.